期刊文献+

鞘氨醇激酶1在胃癌组织中的表达及其与肿瘤浸润转移及预后的关系 被引量:6

Relationship between sphingosine kinase 1 expression and tumor invasion, metastasis and prognosis in gastric cancer
原文传递
导出
摘要 目的探讨鞘氨醇激酶1(SPHK1)在胃癌组织中的表达及其与胃癌浸润、转移及预后的关系。方法应用免疫组织化学SP法,检测浙江省人民医院2001年1月至2005年12月206例石蜡固定的胃癌组织和同期的40例非肿瘤胃黏膜中SPHK1的表达。结果在40例非肿瘤胃黏膜组织中,3例(7.5%)SPHKl蛋白为阳性表达,均为低表达。在206例胃癌组织中,181例(87.9%)SPHK1蛋白阳性表达,明显高于非肿瘤胃黏膜组织(P=0.001),其中高表达126例(61.2%)。SPHK1蛋白的表达与浸润深度、淋巴结转移、远处转移及TNM分期有关(P=0.039、0.003、0.020、0.003),而与患者性别、肿瘤部位、肿瘤大小、分化程度和组织学类型无关(均P〉0.05)。Ⅰ~Ⅱ和Ⅲ期中SPHK1高表达胃癌患者5年生存率显著低于SPHK1低表达者[53.6%(15/28)比68.6%(24/35),7.8%(6/77)比30.8%(12/39),P=0.009、0.006],Ⅳ期胃癌患者的5年生存率与SPHK1表达无关(P〉0.05),多变量分析表明SPHK1表达、淋巴结转移、远处转移和TNM分期是胃癌患者独立的预后因素。结论SPHK1的表达与胃癌淋巴结转移和远处转移及预后相关,SPHK1有望成为一个预测肿瘤预后的分子标志物。 Objective To explore the clinical significance of sphingosine kinase 1 (SPHK1) in the invasion, metastasis and prognosis of gastric cancer. Methods Immunohistochemistry was employed to analyze the expression of SPHK1 in 206 clinicopathologically characterized gastric cancer cases from January 2001 to December 2005 at Zhejiang Provincial People's Hospital. Results SPHK1 protein was detected in 3 (7. 5% ) of 40 human non-tumor mueosa. All samples expressed the protein at a low level. SPHK1 protein was detected in 181 (87. 9% ) of 206 human gastric cancer cases. An elevated expression of SPHK1 protein was detected in 126 (61.2%) tumors. And SPHK1 protein was up-regnlated in gastric cancer lesions compared with adjacent noncancerous tissues( P = 0. 001 ). The expression of SPHK1 was correlated with the depth of invasion, lymph node metastasis, distant metastasis and TNM stage ( P = 0. 039, 0. 003, 0. 020, 0. 003 ). In stages I - 11 and m, the 5-year survival rate of the patients with a high expression of SPHK1 was significantly lower than those with a low expression ( 53.6% ( 15/28 ) vs 68. 6% ( 24/35 ), 7.8% ( 6/ 77)vs 30. 8% (12/39) ,P =0. 009 , 0. 006). In stage IV, the expression of SPHK1 was not correlated with the 5-year survival rate ( P 〉 O. 05 ). Further muhivariate analysis suggested that lymph node metastasis, distant metastasis, TNM stage and the up-regulation of SPHK1 were independent prognostic indicators for gastric cancer. Conclusion The expression of SPHK1 in gastric cancer is significantly associated with lymph node metastasis, distant metastasis and a poor prognosis. SPHK1 may become a useful marker of predicting tumor progression and prognosis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2011年第39期2765-2768,共4页 National Medical Journal of China
关键词 胃肿瘤 预后 鞘氨醇激酶 Stomach neoplasms Prognosis Sphingosine kinase
  • 相关文献

参考文献14

  • 1詹文华,韩方海.我国胃癌外科治疗的现状和思考[J].实用肿瘤杂志,2008,23(2):91-93. 被引量:37
  • 2Akao Y,Banno Y,Nakagawa Y,et al.High expression of sphingosine kinase 1 and SIP receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up regulation.Biochem Biophys Res Commun,2006,342:1284-1290.
  • 3Fukuoka J,Fujii T,Shih JH,et al.Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.Clin Cancer Res,2004,10:4314.
  • 4Yasui W,Oue N,Aung PP,et al.Molecular-pathological prognostic factors of gastric cancer:a review.Gastric Cancer,2005,8:86-94.
  • 5Malavaud B,Pchejetski D,Mazerolles C,et al.Sphingosine kinase-1 activity and expression in human prostate cancer resection specimens.Eur J Cancer,2010,46:3417-3424.
  • 6Facchinetti MM,Gandini NA,Fermento ME,et al.The expression of sphingosine kinase-1 in head and neck carcinoma.Cells Tissues Organs,2010,192:314-324.
  • 7Li J,Guan HY,Gong LY,et al.Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival.Clin Cancer Res,2008,14:6996-7003.
  • 8Song L,Xiong H,Li J,et al.Sphingosine kinase-1 enhances resistance to apoptosis through activation of P13K/Akt/NF {kappa} B pathway in human non-small cell lung cancer.Clin Cancer Res,2011,17:1839-1849.
  • 9Li W,Yu CP,Xia JT,et al.Sphingosine kinase 1 is associated with gastric cancer progression and poor survival of patients.Clin Cancer Res,2009,15:1393-1399.
  • 10Shirai K,Kaneshiro T,Wada M,et al.A role of sphingosine kinase 1 in head and neck carcinogenesis.Cancer Prev Res (Phila),2011,4:454-462.

共引文献36

同被引文献35

  • 1Lin Chen Tao Li Rong Li Bo Wei Zheng Peng.Alphastatin downregulates vascular endothelial cells sphingosine kinase activity and suppresses tumor growth in nude mice bearing human gastric cancer xenografts[J].World Journal of Gastroenterology,2006,12(26):4130-4136. 被引量:7
  • 2Heo K, Park KA, Kim YH, et al. Sphingosine 1 phosphate in- duces vascular endothelial growth factor expression in endotheli- al cells[J]. BMB Rep,2009,42(10) :685-690.
  • 3Karamysheva AF. Mechanisms of angiogenesis[J]. Biochemistry (Mosc),2008,73(7):751-762.
  • 4Joki T, Machluf M,Atala A, et al. Continous release of endosta- tin form microencapasulated engineered cells for tumor therapy [J]. Nat Biotechnol,2001,19(1):35-39.
  • 5Carmeliet P,Jain RK. Molecular mechanisms and clinical applica tions of angiogenesis[J]. Nature,2011,473(7347) :298-307.
  • 6Pan J, Tao YF, Zhou Z, et al. An novel role of sphingosine ki- nase-1 (SPHK1) in the invasion and metastasis of esophageal carcinoma[J]. J Transl Med,2011,9 :157.
  • 7Fujii Y, Ueda Y, Ohtake H, et al. Blocking S1P interaction with S1P 1 receptor by a novel competitive S1P 1-selective antagonist inhibits angiogenesis[J]. Biochem Biophys Res Commun, 2012, 419(4) :754-760.
  • 8Chiba Y,Takeuchi H,Sakai H,et al. SKI-1I,an inhibitor of sphingo- sine kinase, ameliorates antigen-induced bronchial smooth muscle hy- perresponsiveness, but not airway inflammation, in mice [ J]. J Phar macol Sci,2010,114(3) :304-310.
  • 9Saddoughi SA,Song P, Ogretmen B. Role of bioactive sphingolip- ids in cancer biology and therapeutics[J]. Subcell Biochem, 2008, 49 : 413-440.
  • 10Weidner N,Semple JP,Welch WR,et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma[J]. N Engl J Med,1991,324(1):1- 8.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部